NBNoémi Bilakovics

Noémi Bilakovics

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Noémi Bilakovics has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    MHC Molecules on B Cell Microvilli Are Spatially Associated with IL-15Rα

    by István Rebenku, Noémi Bilakovics, Levente Szolyka, Lukas Velas, Tamás Garda, Gerhard J. Schütz, György Vámosi

    Interleukin-15 (IL-15) trans-presentation (TP) by B cells is an important mechanism of T-cell activation; however, the spatial organisation of interleukin-15 receptor α (IL-15Rα) relative to major histocompatibility complex (MHC) molecules on B-cell microvilli remains poorly understood. As microvilli protrude from the B-cell surface and may serve as sites of initial B-cell–T-cell contact, the distribution of IL-15Rα and MHC molecules within these structures may contribute to the earliest stages of T-cell recognition and activation. Here, we investigated the spatial association and molecular proximity of IL-15Rα with MHC class I and class II molecules on B-cell microvilli before immunological synapse formation, using confocal microscopy, stimulated emission depletion (STED) microscopy, stochastic optical reconstruction microscopy (STORM), and fluorescence lifetime imaging microscopy–based Förster resonance energy transfer (FLIM-FRET). Both MHC class I and MHC class II molecules showed a significant spatial association with IL-15Rα; however, the extent of colocalisation decreased as the spatial resolution increased. STED microscopy revealed significant colocalisation between IL-15Rα and MHC class I, whereas STORM did not detect this association. In contrast, IL-15Rα and MHC class II remained significantly colocalised at both resolutions. FLIM–FRET further demonstrated molecular proximity between IL-15Rα and both MHC class I and MHC class II molecules, with higher FRET efficiency observed for MHC class II. Collectively, these findings indicate that IL-15Rα is spatially organised in proximity to both MHC class I and class II molecules on B-cell microvilli before immunological synapse formation. This arrangement at potential sites of initial B cell–T cell contact may facilitate the coordination of IL-15 trans-presentation and antigen presentation during the earliest stages of B cell–T cell interactions.

  • Open Access

    Hierarchical Functionalisation of UiO-66(Zr)-NH2 with Cysteine, PEG, and SARS-CoV-2 Spike RBD to Facilitate ACE2 Receptor Targeting in Model Cells

    by Veronika Huntošová, Saraa Baddour, Alexandra Migasová, Noémi Bilakovics, Anass Benziane, Michaela Salaková, Zuzana Jurašeková, Tomáš Zelenka, Gabriela Zelenková, Tim Schubert, et al.

    Hierarchical functionalisation of the UiO-66(Zr)-NH2 metal–organic framework with cysteine, poly(ethylene glycol) (PEG), and the SARS-CoV-2 spike receptor-binding domain (RBD) was developed to enable receptor-specific interaction with the angiotensin-converting enzyme 2 receptor (ACE2) in model cells. Post-synthetic modification using cysteine and heterobifunctional PEG linkers allowed controlled bioconjugation of SpyTag-labelled RBD via SpyTag/SpyCatcher chemistry, while preserving the crystallinity, microporosity, and intrinsic optical properties of the UiO-66(Zr)-NH2 framework. Comprehensive physicochemical characterisation confirmed successful surface functionalisation, tunable aggregation behaviour, and retention of multimodal optical characteristics. Cellular studies in HEK293T and HeLa cells overexpressing EGFP-tagged ACE2 demonstrated enhanced and selective association and uptake of RBD-functionalised nanoparticles compared with non-targeted analogues. Multimodal fluorescence imaging, fluorescence lifetime imaging microscopy, flow-cytometry, and electron microscopy indicated ACE2-dependent endocytic internalisation, with predominant localisation in endosomal and autophagosomal compartments, while both amine- and cysteine-modified formulations exhibited good biocompatibility. Overall, this study establishes a virus-mimetic, ACE2-targeted UiO-66(Zr)-based nanosystem as a proof-of-concept biointerface platform for receptor-specific cellular delivery and imaging, providing a foundation for future MOF-based nanocarriers exploiting ligand–receptor interactions.